Logo image of COSM

COSMOS HEALTH INC (COSM) Stock Fundamental Analysis

USA - NASDAQ:COSM - US2214133058 - Common Stock

1.02 USD
0 (0%)
Last: 10/23/2025, 1:16:05 PM
Fundamental Rating

1

Taking everything into account, COSM scores 1 out of 10 in our fundamental rating. COSM was compared to 101 industry peers in the Health Care Providers & Services industry. COSM may be in some trouble as it scores bad on both profitability and health. COSM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

COSM had negative earnings in the past year.
In the past year COSM has reported a negative cash flow from operations.
COSM had negative earnings in 4 of the past 5 years.
In the past 5 years COSM always reported negative operating cash flow.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

COSM's Return On Assets of -34.88% is on the low side compared to the rest of the industry. COSM is outperformed by 89.11% of its industry peers.
COSM's Return On Equity of -82.22% is on the low side compared to the rest of the industry. COSM is outperformed by 77.23% of its industry peers.
Industry RankSector Rank
ROA -34.88%
ROE -82.22%
ROIC N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

With a Gross Margin value of 9.85%, COSM is not doing good in the industry: 75.25% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of COSM has declined.
COSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

1

2. Health

2.1 Basic Checks

COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
COSM has more shares outstanding than it did 1 year ago.
COSM has more shares outstanding than it did 5 years ago.
COSM has a worse debt/assets ratio than last year.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

COSM has an Altman-Z score of -2.03. This is a bad value and indicates that COSM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COSM (-2.03) is worse than 86.14% of its industry peers.
COSM has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
COSM has a Debt to Equity ratio of 0.26. This is in the better half of the industry: COSM outperforms 67.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -2.03
ROIC/WACCN/A
WACC7.21%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

COSM has a Current Ratio of 0.98. This is a bad value and indicates that COSM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.98, COSM is doing worse than 73.27% of the companies in the same industry.
COSM has a Quick Ratio of 0.98. This is a bad value and indicates that COSM is not financially healthy enough and could expect problems in meeting its short term obligations.
COSM has a Quick ratio of 0.82. This is in the lower half of the industry: COSM underperforms 77.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.82
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

COSM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.35%, which is quite impressive.
COSM shows a decrease in Revenue. In the last year, the revenue decreased by -2.41%.
The Revenue has been growing slightly by 6.52% on average over the past years.
EPS 1Y (TTM)51.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.28%
Revenue 1Y (TTM)-2.41%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%11.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y101.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COSM. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 100.00 indicates a quite expensive valuation of COSM.
The rest of the industry has a similar Price/Forward Earnings ratio as COSM.
The average S&P500 Price/Forward Earnings ratio is at 23.09. COSM is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 100
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

COSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COSMOS HEALTH INC

NASDAQ:COSM (10/23/2025, 1:16:05 PM)

1.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-26 2025-08-26
Earnings (Next)11-12 2025-11-12
Inst Owners3.33%
Inst Owner Change0%
Ins Owners28.16%
Ins Owner Change13.04%
Market Cap30.81M
Revenue(TTM)55.09M
Net Income(TTM)-21566900
Analysts82.86
Price Target3.06 (200%)
Short Float %2.25%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.27%
Min Revenue beat(2)-17.28%
Max Revenue beat(2)-13.27%
Revenue beat(4)0
Avg Revenue beat(4)-11.86%
Min Revenue beat(4)-17.28%
Max Revenue beat(4)-3.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 100
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 1.71
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)0.01
Fwd EY1%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS1.82
BVpS0.87
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.88%
ROE -82.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.85%
FCFM N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
F-Score4
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 99.4%
Cap/Sales 2.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.82
Altman-Z -2.03
F-Score4
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)567.53%
Cap/Depr(5y)400.27%
Cap/Sales(3y)5.71%
Cap/Sales(5y)3.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.28%
EPS Next Y101.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.41%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%11.65%
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y78.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.22%
OCF growth 3YN/A
OCF growth 5YN/A